🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchMonthly semaglutide depot formulation — my results so far Page 8

Monthly semaglutide depot formulation — my results so far

tony_orlando Mon, Jul 22, 2024 at 3:23 PM 39 replies 2,686 viewsPage 8 of 8
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Sep 10, 2024 at 1:13 PM#36
Dr.NateNeph said:
Practical: whatever you change, write down the date and the reason.

Saving this. It is the first explanation that did not require me to already understand it. Printing the relevant bit and taking it with me.

Last edited: Sep 10, 2024 at 5:13 PM
34 7wanda_boise, NurseAsh_DET, BenResearch_OR and 31 others
Reply Quote Save Share Report
pete_nash
Member
312
1,345
Aug 2024
Nashville, TN
Sep 13, 2024 at 7:15 AM#37

Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

35 8Dr.Martinez, mike_mod, SarahChen_PharmD and 32 others
Reply Quote Save Share Report
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Sep 16, 2024 at 1:15 AM#38
pete_nash said:
The useful move here is to separate what is established from what is widely repeated.

This is my experience too, for whatever a second data point is worth. I had assumed I was the exception until I read this.

Last edited: Sep 16, 2024 at 3:15 AM
36 9DoseLogDan, SleepFixSam, PurityPaulOR and 33 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
alex_tucson
Member
567
2,345
May 2024
Tucson, AZ
Sep 18, 2024 at 7:13 PM#39
pete_nash said:
The useful move here is to separate what is established from what is widely repeated.

Coming at pete_nash’s question from a different direction. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

37 10ricardo_MIA, BrianDallas92, labquiet_amy and 34 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Sep 21, 2024 at 1:10 PM#40

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

9 7Dr.DermMIA, fiona_VT, denise_HTX and 6 others
Reply Quote Save Share Report
1678

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register